Long-term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: a Propensity Score-Matched

Chan-Young Kim

Long-term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: a Propensity Score-Matched

Chan-Young Kim

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	Journal of Gastric Cancer
State	Published - 2020.06.1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{7fbe3516a5fc4e6bb8d0ac88547840a3,

title = "Long-term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: a Propensity Score-Matched",

author = "Chan-Young Kim",

year = "2020",

month = jun,

day = "1",

language = "Korean",

journal = "Journal of Gastric Cancer",

issn = "2093-582X",

}